Is orthopedics ready for implantable brain chips and telepathic large joint movement? FDA cleared Neuralink’s first implant ...

Centinel Spine and its new “Match the Disc” program, fueled a whopping 33% sales growth rate for Q1, 2025. To put that in ...

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) study for a novel bone graft substitute. What makes this novel, is that this bone graft substitute ...

NuVasive loses patent fight over certain pedicle screws and bone anchors. The winning plaintiff is Roger P. Jackson M.D.

The FDA recently cleared a novel treatment for osteopenia. When OTW spoke with CEO Laura Yecies, we found both a very interesting new product and an interesting leader who is charting a novel path to ...

Two investigational drugs are progressing through the regulatory pipeline with notable promise, aiming to address two of the most persistent and impactful comorbidities in orthopedic medicine: smoking ...

Gentamycin loaded UHMPWE? Impossible you say? Mass General’s “Eureka” moment, now a paper in JBJS, showed its possible, with ...

Get full access to Orthopedics This Week articles, PDF versions our our newsletters, access to the newsletter archives, and more!

How you win, how you lose, is sometimes more interesting than the contest itself. In this case, Kevin Plancher, M.D. and lead critic of AAOS’s proposal to update their bylaw for the 21st century, ...